CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

SSKN is no longer listed: the SEC shows no trading symbol for it and it has no recent price, usually after an acquisition. CatalystAlert no longer tracks its catalysts.

STRATA Skin Sciences, Inc.

SSKN
$718KMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for SSKN. That does not mean none is planned.

Get an email about SSKN's next catalysts

Track STRATA Skin Sciences (SSKN) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

How SSKN's past catalysts played out

Market Overview

Stock performance and key metrics

NASDAQSurgical & Medical Instruments & ApparatusπŸ‡ΊπŸ‡ΈNorth AmericaHORSHAM

Strata Skin Sciences (formerly MELA Sciences, Inc.) is an American medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations.

Website
Drug Pipeline

No drugs found in this phase.

Frequently asked questions

When is STRATA Skin Sciences, Inc.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for STRATA Skin Sciences, Inc. (SSKN) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track SSKN biotech catalysts?β†’

Add SSKN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow STRATA Skin Sciences, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply